Patents
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
06/2013
06/04/2013US8455457 Combination compositions for reducing intraocular pressure
06/04/2013CA2545660C Heterocyclic inhibitors of mek and methods of use thereof
06/04/2013CA2545659C Bicyclic inhibitors of mek
05/2013
05/30/2013WO2013078123A1 Heterocyclic inhibitors of glutaminase
05/30/2013WO2013076590A1 Benzothiazine compounds as h3 receptor ligands
05/30/2013WO2012140596A8 Glycoside derivatives and uses thereof
05/30/2013US20130137875 Nucleic acid detections and methods of their use
05/30/2013US20130137842 Organic semiconductor compound, and organic thin film including the organic semiconductor compound
05/30/2013US20130137728 Compositions and Methods for the Treatment of Degenerative Diseases
05/30/2013US20130137703 Aminopyridine kinase inhibitors
05/30/2013US20130137699 Therapeutic compounds
05/30/2013US20130137684 Haematopoietic-prostaglandin d2 synthase inhibitors
05/30/2013US20130137679 Novel Functionally Selective Ligands of Dopamine D2 Receptors
05/30/2013US20130137674 Azetidinyl diamides as monoacylglycerol lipase inhibitors
05/30/2013US20130137673 Inhibitors of jak
05/30/2013US20130137661 Gonadotropin Releasing Hormone Receptor Antagonist, Preparation Method Thereof And Pharmaceutical Composition Comprising The Same
05/30/2013US20130137660 Inhibitors of kinase activity
05/30/2013US20130137648 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors
05/30/2013US20130136794 Heteroaryl (alkyl) dithiocarbamate compounds, preparation methods and uses thereof
05/30/2013CA2856386A1 Heterocyclic inhibitors of glutaminase
05/30/2013CA2856306A1 Selective kinase inhibitors
05/30/2013CA2856301A1 Pyrazine kinase inhibitors
05/29/2013EP2597093A1 Benzofuranone compound and pharmaceutical composition containing same
05/29/2013EP2597089A1 Tricyclic heterocyclic compounds
05/29/2013EP2597088A1 P2x4 receptor antagonist
05/29/2013EP2596793A1 Quinoline derivatives as PI3 kinase inhibitors
05/29/2013EP2595986A2 Novel 2-amino-4-pyrazolyl-thiazole derivatives and their use as allosteric modulators of metabotropic glutamate receptors
05/29/2013EP2595985A1 Isoxazole, isothiazole, furane and thiophene compounds as microbicides
05/29/2013EP2595984A1 Microbicides
05/29/2013EP2595983A1 2,3,5-trisubstituted thiophene compounds and uses thereof
05/29/2013EP2595981A1 Novel hetaryl (thio)carboxamide compounds for controlling invertebrate pests
05/29/2013EP2595483A1 Novel pyrrolidine derived beta 3 adrenergic receptor agonists
05/29/2013DE102011055815A1 Carboxamid-substituierte Heteroaryl-Pyrazole und ihre Verwendung Carboxamide substituted heteroaryl-pyrazoles and their use
05/29/2013CN103124729A Pharmaceutically active compounds as Axl inhibitors
05/29/2013CN103124724A Arylcyclopropylamine based demethylase inhibitors of LSD1 and their medical use
05/29/2013CN103121997A Compound having thiadiazole ring structure substituted with pyridyl group and organic electroluminescent device
05/29/2013CN103121996A Novel heteroaryl-substituted arylaminopyridine derivatives as mek inhibitors
05/29/2013CN102391263B Deuteroacetyl-containing kinase inhibitor
05/29/2013CN102219750B N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase
05/29/2013CN102066369B Bromo-phenyl substituted thiazolyl dihydropyrimidines
05/29/2013CN101891706B 3,4-dihydrobenzo[f][1,4]thiazepine compound or salts of same and medical use of same
05/29/2013CN101835765B Alkylsulfonyl-substituted thiazolide compounds
05/29/2013CN101490023B Modulators of pharmacokinetic properties of therapeutics
05/29/2013CN101466710B Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
05/28/2013US8450481 Compounds for inhibiting protein aggregation, and methods for making and using them
05/28/2013US8450478 Cyclic guanidine ionic liquid
05/28/2013US8450352 Thiazole compounds and their use for inhibiting phosphodiesterase 4, TNF-α, and IL-4
05/28/2013US8450351 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
05/28/2013US8450347 Administering a protein fraction, digestible carbohydrates, and a combination of folate, and one of vitamin B6 and vitamin B12.
05/28/2013US8450310 Isoxazole compounds as inhibitors of heat shock proteins
05/28/2013CA2744756C Monocarbams and their use as antibacterial agent
05/28/2013CA2598301C Salt of proline derivative, solvate thereof, and production method thereof
05/28/2013CA2577467C Hiv inhibiting 5-heterocyclyl pyrimidines
05/28/2013CA2558647C Insecticidal n-substituted sulfoximines
05/28/2013CA2547887C Protein modifier production inhibitor
05/28/2013CA2530886C Dual nk1/nk3 antagonists for treating schizophrenia
05/28/2013CA2464353C Linear basic compounds having nk-2 antagonist activity and formulations thereof
05/23/2013WO2013074641A1 Piperidinyl- substituted cyclic ureas as gpr119 modulators
05/23/2013WO2013074059A2 Cytosine deaminase modulators for enhancement of dna transfection
05/23/2013WO2013073577A1 Dihydroxy aromatic heterocyclic compound
05/23/2013WO2013072402A1 Substituted 1,2,5-oxadiazole compounds and their use as herbicides ii
05/23/2013WO2013072015A1 Morpholinyl benzotriazine for use in cancer therapy
05/23/2013WO2013071694A1 Oxazole compound and preparation method, pharmaceutical composition and use thereof
05/23/2013WO2013071693A1 Oxadiazole compound and preparation method thereof, pharmaceutical composition and use thereof
05/23/2013WO2013049382A3 Broad-spectrum antivirals against 3c or 3c-like proteases of picornavirus-like supercluster: picornaviruses, caliciviruses and coronaviruses
05/23/2013US20130131338 Substituted diketopiperazines as oxytocin antagonists
05/23/2013US20130131324 Novel Fluorescent Dyes and Uses Thereof
05/23/2013US20130131321 LIGANDS FOR ANTIBODY AND Fc-FUSION PROTEIN PURIFICATION BY AFFINITY CHROMATOGRAPHY
05/23/2013US20130131114 Novel alkene oxindole derivatives
05/23/2013US20130131109 Bicyclic derivatives as modulators of voltage gated ion channels
05/23/2013US20130131099 Compounds and methods of treating brain disorders
05/23/2013US20130131092 Novel amido derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors
05/23/2013US20130131085 Cytochrome p450 oxidase inhibitors and uses thereof
05/23/2013US20130131063 Compounds and Methods for Inhibiting the Interaction of BCL Proteins with Binding Partners
05/23/2013US20130131062 Pyridazinones and furan-containing compounds
05/23/2013US20130131061 Novel Estrogen Receptor Ligands
05/23/2013US20130131052 Amelioration Of The Development Of Cataracts And Other Ophthalmic Diseases
05/23/2013US20130131051 Compounds for the reduction of beta-amyloid production
05/23/2013US20130131044 Selective glycosidase inhibitors and uses thereof
05/23/2013US20130131040 Pyrazine kinase inhibitors
05/23/2013US20130131037 2-(heterocyclylbenzyl)pyridazinone derivatives
05/23/2013US20130126856 Compound having indenocarbazole ring structure, and organic electroluminescent device
05/23/2013US20130126429 Amine sulfide scavengers, methods of using, and methods of making
05/23/2013CA2856103A1 Morpholinyl benzotriazine for use in cancer therapy
05/23/2013CA2853340A1 Substituted 1,2,5-oxadiazole compounds and their use as herbicides ii
05/22/2013EP2594566A1 Nitrogenated aromatic heterocyclic ring derivative
05/22/2013EP2594265A1 Ca ix-specific inhibitors
05/22/2013EP2593449A1 Process for the synthesis of benzothiadiazole compounds
05/22/2013EP2592933A1 Mif inhibitors and their uses
05/22/2013CN103119038A 4 - (5 - isoxazolyl or 5 - pyrrazolyl -1,2,4- oxadiazol - 3 - yl) -mandelic acid amides as sphingosin- 1 - phosphate 1 rreceptor agonists
05/22/2013CN103119036A Heterocyclic compounds as agents for pest control
05/22/2013CN103119034A Novel heterocyclic compounds as pest control agents
05/22/2013CN103119031A 取代酰胺化合物 Substituted amide compounds
05/22/2013CN103113365A rhodanine quinazolinamine compound as well as preparation method and application thereof
05/22/2013CN102134214B Isoindolone compounds and their use as metabotropic glutamate receptor potentiators
05/22/2013CN101687786B Hydroxylamine compounds and methods of their use
05/22/2013CN101528713B Pyridazine derivatives used as 11 beta-hydroxysteroid dehydrogenase type 1 inhibitors
05/22/2013CN101479250B Tetrazole-substituted arylamides
05/21/2013US8445694 Hydrazonopyrazole derivatives and their use as therapeutics
05/21/2013US8445690 Aminothiazolones as estrogen related receptor-alpha modulators
1 ... 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 ... 628